Clinical trialNCT01447706CompletedPhase 2Interventional

A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers

SponsorMerrimack PharmaceuticalsEnrollment223Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To determine whether the combination of MM-121 plus paclitaxel is more effective than paclitaxel alone

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Victor Moyo, MD
Merrimack Pharmaceuticals
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Arizona Center for Cancer Care
Glendale, Arizona, United States
Pinnacle Oncology
Scottsdale, Arizona, United States
Comprehensive Blood and Cancer Center
Bakersfield, California, United States
Wilshire Oncology Medical Group
Corona, California, United States
North County Oncology
Oceanside, California, United States
Central Coast Medical Oncology
Santa Maria, California, United States
Indiana University Simon Cancer Center
Indianapolis, Indiana, United States
Carolinas Medical Center/blumenthal Cancer Center
Charlotte, North Carolina, United States
Promedica Health System, Inc.
Toledo, Ohio, United States
Chattanooga Gyn Oncology
Chattanooga, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MM-121Paclitaxel

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Oct 2011
Primary completion: 30 Sept 2013
Completion: 30 Jun 2015
Last update posted: 12 May 2016
Registered enrollment: 223
Registry id: NCT01447706

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.